City

Clinical trials near Durham, United States

Active studies with a listed research site in Durham, United States.

15active studies

11recruiting now

2countries represented

140largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, OverweightCondition

aleniglipron, aleniglipronTreatment

United States74 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-09-01 · NCT07654374See eligibility →

Recruiting nowPhase 4

Tirzepatide in Idiopathic Intracranial Hypertension Trial

Idiopathic Intracranial Hypertension (IIH)Condition

Tirzepatide, Tirzepatide PlaceboTreatment

United States1 locations

Duke UniversitySponsor

Updated 2026-08-28 · NCT07191873See eligibility →

Recruiting nowPhase 3

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Alcohol Use DisorderCondition

Semaglutide, PlaceboTreatment

United States19 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-08-12 · NCT07218354See eligibility →

Recruiting nowPhase 3

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, OverweightCondition

Aleniglipron, PlaceboTreatment

United States71 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-08-10 · NCT07654361See eligibility →

Recruiting nowNot applicable

Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)

Asthma in Children, ObesityCondition

Pro2 - Low Dose - 40% of participant's MIP, Pro2 - High Dose - 75% of participant's MIPTreatment

United States2 locations

Duke UniversitySponsor

Updated 2026-08-05 · NCT05945355See eligibility →

Recruiting nowPhase 4

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Type2Diabetes, ASCVDCondition

SGLT2 inhibitor, GLP-1 receptor agonistTreatment

United States36 locations

Brigham and Women's HospitalSponsor

Updated 2026-04-13 · NCT05390892See eligibility →

Recruiting nowNot applicable

Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health

Pediatric Obesity, Food InsecurityCondition

Grocery intervention - unrestricted, Grocery intervention - restrictedTreatment

United States1 locations

Duke UniversitySponsor

Updated 2026-01-16 · NCT06116422See eligibility →

Recruiting nowNot applicable

Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma

Pediatric Obesity, Pediatric AsthmaCondition

Pro2 - 60% of participant's MIP, Pro2 - 15% of participant's MIPTreatment

United States1 locations

Duke UniversitySponsor

Updated 2025-08-22 · NCT05608668See eligibility →

Recruiting nowPhase 2

Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes

Asthma, ObesityCondition

L-ctirulline, Matching PlaceboTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2025-06-10 · NCT03885245See eligibility →

Recruiting nowNot applicable

International Weight Control Registry

Weight Loss, OverweightCondition

Intervention not listedTreatment

United States7 locations

Tufts UniversitySponsor

Updated 2024-09-19 · NCT04907396See eligibility →

Recruiting nowNot applicable

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

Insulin Resistance, Impaired Glucose ToleranceCondition

Low Physical Activity and Added Carbohydrate Group, Low physical Activity ControlTreatment

United States1 locations

University of New HampshireSponsor

Updated 2024-07-17 · NCT05912348See eligibility →

Opening soonNot applicable

Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity

Childhood ObesityCondition

FBT 2.0, Information-and-referralTreatment

United States1 locations

3-C Institute for Social DevelopmentSponsor

Updated 2026-09-02 · NCT06728800See eligibility →

Active, not recruitingPhase 2

MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial

Adult Obesity, Weight ManagementCondition

ECC4703, PlaceboTreatment

United States15 locations

EccogeneSponsor

Updated 2026-06-25 · NCT07505303See eligibility →

Active, not recruitingPhase 4

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

ObesityCondition

Naltrexone-Bupropion (NB) Combination, PlaceboTreatment

United States140 locations

Currax PharmaceuticalsSponsor

Updated 2026-03-31 · NCT06098079See eligibility →

Active, not recruitingPhase 3

VK2735 for Weight Management Phase 3

Weight LossCondition

VK2735Treatment

Puerto Rico, United States137 locations

Viking Therapeutics, Inc.Sponsor

Updated 2025-11-24 · NCT07104500See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Durham, United States

Current studies

Related cities